Manzana Family Medicine Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 2410 Commerce Trl, Imperial, CA 92251 Phone: 760-332-8688 |
Mervat Kelada M.d. A Medical Corp Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 207 E Barioni Blvd Ste A, Imperial, CA 92251 Phone: 760-355-2999 Fax: 760-355-4150 |
Imperial Valley Family Care Medical Group Apc General Practice Medicare: Medicare Enrolled Practice Location: 516 West Aten Road, Suite 2, Imperial, CA 92251 Phone: 760-355-7730 Fax: 760-355-7731 |
Mari Carlo Manzana, M.d., Inc. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2410 Commerce Trl, Imperial, CA 92251 Phone: 661-714-1560 |
Mervat Kelada M D A Medical Corporation Family Medicine Medicare: Medicare Enrolled Practice Location: 207 E Barioni Blvd, Imperial, CA 92251 Phone: 760-355-2999 Fax: 760-355-4150 |
Centerpoint Medical Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 388 W Aten Rd Ste D, Imperial, CA 92251 Phone: 760-545-0411 |
News Archive
Mayo Clinic today announced that OSF HealthCare passed Mayo's rigorous review process to become the newest member of the Mayo Clinic Care Network.
Consumer Watchdog condemned the removal of the Medicare buy-in provision for those over 55 and the public option from the U.S. Senate health reform bill. But the group said that the Senate must still make three essential fixes to the greatly weakened bill to prevent ceding the entire health care system to the insurance industry.
The finding by researchers at Washington University School of Medicine in St. Louis shows that an enzyme known as cathepsin G regulates the ability of immune cells known as neutrophils to secrete chemicals that attract other immune cells and start the local inflammatory process. Over time, the excessive accumulation of immune cells can lead to tissue and cartilage damage in joints, causing pain and limiting mobility.
On March 24, Nancy Muller, executive director of The National Association For Continence (NAFC), spoke to the Food and Drug Administration (FDA), in support of a Premarket Approval Application (PMAA) of Uromedica, Inc.'s Adjustable Continence Therapy (ACT®) device to approve its usage in the U.S. The ACT is designed to treat female stress urinary incontinence (SUI).
› Verified 4 days ago